Glenmark Pharma Beats Suit Over Recalled Cholesterol Drugs
A New Jersey federal judge Wednesday tossed a proposed class action that accused drugmaker Glenmark Pharmaceuticals of falsely representing that its statin cholesterol drugs were safe and effective despite a recall...To view the full article, register now.
Already a subscriber? Click here to view full article